Reference
·Supporting source
Thailand pharmaceutical distributor market share (2024)
DKSH ~25-28%
DKSH Thailand leads the pharmaceutical distribution market at roughly 25-28% share in 2024 per industry estimates, anchored by its multinational originator drug portfolio (Novartis, Pfizer, Roche, GSK distribution contracts). Zuellig Pharma Thailand sits second at approximately 18-22%, MediOne (subsidiary of Berli Jucker) at 8-12% in specialty and hospital channels, and DCH Auriga (Pacific Healthcare) at 5-8% in oncology and biologics distribution. The residual 30-40% fragments across Sino-Thai Engineering & Construction-affiliated, Diethelm Keller legacy operations, and dozens of regional sub-distributors serving upcountry provinces.
Figure in context
DKSH Thailand leads the pharmaceutical distribution market at roughly 25-28% share in 2024 per industry estimates, anchored by its multinational originator drug portfolio (Novartis, Pfizer, Roche, GSK distribution contracts). Zuellig Pharma Thailand sits second at approximately 18-22%, MediOne (subsidiary of Berli Jucker) at 8-12% in specialty and hospital channels, and DCH Auriga (Pacific Healthcare) at 5-8% in oncology and biologics distribution. The residual 30-40% fragments across Sino-Thai Engineering & Construction-affiliated, Diethelm Keller legacy operations, and dozens of regional sub-distributors serving upcountry provinces.
Interpretation notes
What this tells you
DKSH Thailand leads the pharmaceutical distribution market at roughly 25-28% share in 2024 per industry estimates, anchored by its multinational originator drug portfolio (Novartis, Pfizer, Roche, GSK distribution contracts). Zuellig Pharma Thailand sits second at approximately 18-22%, MediOne (subsidiary of Berli Jucker) at 8-12% in specialty and hospital channels, and DCH Auriga (Pacific Healthcare) at 5-8% in oncology and biologics distribution. The residual 30-40% fragments across Sino-Thai Engineering & Construction-affiliated, Diethelm Keller legacy operations, and dozens of regional sub-distributors serving upcountry provinces.
What not to do with it
Revenue share basis. Multinational originator distribution concentrates in DKSH and Zuellig; generics fragment across regional players.
Related figures
Adjacent numbers that add context without drowning the value.
Thailand pharmaceutical distribution and wholesale revenue (2020-2024)
Pharmaceutical Research and Manufacturers Association, Ministry of Public Health Drug Information Center, Thai FDA
Thailand pharmacy chain store count (2020-2024)
Boots Thailand corporate disclosures, Watsons CK Hutchison investor materials, Pharmacy Council of Thailand registry
DKSH Thailand healthcare segment revenue (2020-2024)
DKSH Group annual reports, DKSH Q4 trading updates, SIX Swiss Exchange disclosures
Thai FDA new drug registration approvals (2020-2024)
Thai Food and Drug Administration annual report, Ministry of Public Health, PReMA regulatory tracking
Government Pharmaceutical Organisation (GPO) state procurement
Government Pharmaceutical Organisation annual report, Ministry of Public Health, National Health Security Office
Thailand pharmaceutical cold-chain share of distribution
PReMA cold-chain working group, DKSH Thailand healthcare disclosure, Thai FDA Good Distribution Practice guidance
Report context
Atlas actors in this figure's reports
Profiles covered in the report that cite this number.